Vasomotor Symptoms of Menopause (Hot Flashes) Pipeline Report, H1 2017 - Therapeutics Review of 8 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2017" report to their offering.

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 6, 2 and 3 respectively.

Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Vasomotor Symptoms of Menopause (Hot Flashes) - Overview
  3. Vasomotor Symptoms of Menopause (Hot Flashes) - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Products under Development by Companies
  7. Vasomotor Symptoms of Menopause (Hot Flashes) - Therapeutics Assessment
  8. Assessment by Target
  9. Assessment by Mechanism of Action
  10. Assessment by Route of Administration
  11. Assessment by Molecule Type
  12. Vasomotor Symptoms of Menopause (Hot Flashes) - Companies Involved in Therapeutics Development
  • EndoCeutics Inc
  • MenoGeniX Inc
  • Millendo Therapeutics Inc
  • Mithra Pharmaceuticals SA
  • Ogeda SA
  • Pherin Pharmaceuticals Inc
  • Radius Health Inc
  • TherapeuticsMD Inc

For more information about this report visit https://www.researchandmarkets.com/research/zf34q8/vasomotor

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health, Sexual and Reproductive Health Drugs